News on Medial

Cosmix by the numbers: What Marico gets in its latest D2C acquisition

EntrackrEntrackr · 1m ago
Cosmix by the numbers: What Marico gets in its latest D2C acquisition
Medial

Continuing its acquisition spree, Mumbai-based multinational consumer goods company Marico has announced the purchase of a 60% majority stake in plant-based protein supplements brand Cosmix, shortly after acquiring snacking brand 4700BC. Cosmix more than doubled its operating scale in the fiscal year ended March 2025 while its profit nearly tripled and has remained profitable since its inception. With this acquisition, Marico has added another brand to its growing D2C portfolio, which includes plant-based nutrition brand Plix, True Elements, Just Herbs, and men’s grooming brand Beardo. To understand the financial drivers behind the acquisition, Entrackr analysed Cosmix’s numbers based on its regulatory filings, along with market signals that appear to have reinforced Marico’s conviction. Cosmix’s revenue from operations more than doubled to Rs 50.93 crore in FY25 from Rs 24.2 crore in FY24. Founded in 2019, Cosmix operates as a digital-first nutrition brand focused on plant-based protein and wellness products, including protein bars, protein pancakes, multivitamins, and immunity boosters. The startup sells its products through its own website and third-party online marketplaces. Sales of these products were the sole source of Cosmix’s operating revenue in FY25. In addition, the company earned Rs 25 lakh as interest on deposits in the last fiscal, which pushed its total income to Rs 51.18 crore. Cosmix is a bootstrapped company and claims to have scaled to an ARR (Annual Recurring Revenue) of Rs 100 crore. Advertising was the largest expense for the D2C firm, accounting for 34% of total expenditure, and doubled year-on-year to Rs 13.52 crore in FY25. The cost of materials was another major expense at Rs 11.2 crore and also doubled during the year, in line with revenue growth. Importantly, the firm’s employee benefits expenses stood at Rs 3.45 crore in the last fiscal which formed only 8.72% of its total costs. Other overheads including marketplace management, transport and courier charges, service retention fees, and software maintenance pushed total expenses to Rs 39.52 crore in FY25. The Bengaluru-based company’s revenue growth outpaced its expenses and led its profit to nearly triple to Rs 8.21 crore in FY25 from Rs 2.83 crore in FY24. The seven-year-old firm has remained profitable since inception, unlike most D2C companies. Its ROCE and EBITDA margin stood at 99.395 and 22.48%, respectively. On a unit level, Cosmix spent Rs 0.78 to earn a rupee. Its current assets were recorded at Rs 16.45 crore, with cash and bank balances of Rs 4.69 crore at the end of FY25. Like Marico, several legacy fast-moving consumer goods (FMCG) companies are increasingly acquiring digital-first (D2C) startups to expand into high-growth categories such as health supplements, grooming, and personal care. Hindustan Unilever (HUL) acquired skincare brand Minimalist, ITC has bought healthy snacking company Yoga Bar, VLCC has picked up men’s grooming brand Ustraa, and Emami has acquired The Man Company, which highlights a broader shift by established FMCG players towards premium, online-native brands. A buy like Cosmix indicates strong conviction at a promoter level or high up in Marico (FY25 revenues of Rs 10,800 crores, PAT of Rs 1,593 crore), considering the relatively small size of the business. It’s not exactly the kind of purchase that will move the stock price either way. Cosmix founders would be expected to leverage Marico’s scale and resources to scale up faster than they would have, besides use their appreciated skills to support other businesses perhaps. One can only hope that Marico will be able to offer the flexibility and space for the Cosmix team to spread out without feeling the constrictions of large firm processes and bureaucracy, an affliction that has laid low expectations from many an acquisition over the years, when it is a large firm acquiring a startup.

Related News

L’Oréal in talks to acquire Bare Anatomy parent Innovist: Report

EntrackrEntrackr · 1h ago
L’Oréal in talks to acquire Bare Anatomy parent Innovist: Report
Medial

L’Oréal in talks to acquire Bare Anatomy parent Innovist: Report French beauty and cosmetics major L’Oréal is in advanced discussions to acquire a majority stake in direct-to-consumer (D2C) personal care startup Innovist, according to a Moneycontrol report. Innovist operates brands such as Bare Anatomy, Chemist at Play, Sunscoop, and Vinci Botanicals. According to the report, the proposed deal is expected to value Innovist between $350 million and $450 million (Rs 3,240–4,170 crore). The move comes as L’Oréal looks to strengthen its position in India. The report added that L’Oréal is expected to initially acquire a controlling stake in Innovist, followed by a gradual increase in ownership to 100% over the next few years. The D2C beauty and wellness space in India has witnessed a wave of strategic acquisitions and consolidation over the past few years, as large FMCG companies look to tap into digitally native brands with strong consumer recall. Recently, Hindustan Unilever Limited acquired the remaining 49% stake in Oziva for Rs 824 crore, following its earlier investments. Last month, pharmaceutical major USV acquired a 79% stake in Wellbeing Nutrition. During the same month, Mumbai-based consumer goods major Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of Rs 375 crore. The trend builds on last year’s consolidation, which included HUL’s acquisition of skincare brand Minimalist at a pre-money valuation of Rs 2,955 crore. If completed at the aforementioned valuation, the L’Oréal–Innovist deal will surpass the HUL–Minimalist deal in size.

Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr

EntrackrEntrackr · 1m ago
Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr
Medial

Hindustan Unilever acquires remaining 49% stake in OZiva for Rs 824 Cr Mumbai-based FMCG major Hindustan Unilever Limited has completed the acquisition of the remaining 49% stake in OZiva, operated through Zywie Ventures Private Limited, for a total consideration of Rs 824 crore. The transaction makes OZiva a wholly owned subsidiary of HUL. The deal shows a sharp jump in OZiva’s valuation. In December 2022, HUL had acquired a 51% stake in OZiva for a cash consideration of Rs 264.28 crore, which implied a valuation of around Rs 518 crore at the time. The latest transaction values the company at nearly Rs 1,682 crore and represents a more than threefold increase over a little more than three years. Founded in 2019, the six-year-old direct-to-consumer firm sells plant-based nutrition products across health, skin, hair, and general wellness categories. Prior to the HUL transaction, OZiva had raised around $17 million from investors such as Matrix Partners, Eight Road Ventures, and Stride Ventures. The company also reported a sharp improvement in operating performance. Its revenue from operations jumped 148% to Rs 258 crore in FY25 from Rs 104 crore in FY24 while losses declined 90% to Rs 4.5 crore in FY25 compared to Rs 43.5 crore in the previous fiscal. The deal follows a series of acquisitions in India’s D2C space this year. On Thursday, pharmaceutical major USV acquired a 79% stake in Wellbeing Nutrition. Earlier this month, Mumbai-based consumer goods major Marico acquired a 60% stake in plant-based protein startup Cosmix at an equity valuation of Rs 375 crore. The trend builds on last year’s consolidation, which included HUL’s acquisition of skincare brand Minimalist at a pre-money valuation of Rs 2,955 crore.

Download the medial app to read full posts, comements and news.